News >

FDA Approves Nivolumab for Advanced Melanoma

Silas Inman @silasinman
Published: Monday, Dec 22, 2014

Dr. Richard Pazdur

Richard Pazdur, MD

The FDA has approved the PD-1 inhibitor nivolumab (Opdivo) for patients with unresectable or metastatic melanoma following treatment with ipilimumab or a BRAF inhibitor, based on data from the phase III CheckMate-037 trial.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication